{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:17Z","timestamp":1761919757562,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.msard.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T10:47:03Z","timestamp":1380019623000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Natalizumab-related progressive multifocal leukoencephalopathy in Greece"],"prefix":"10.1016","volume":"3","author":[{"given":"Dimos D.","family":"Mitsikostas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Mastorodemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minas","family":"Tsagournizakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Kodounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Tsagkaropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Konitsiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Toulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Tavernarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2013.08.006_bib20","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3174\/ajnr.A2035","article-title":"JC virus infection of the brain","volume":"31","author":"Bag","year":"2010","journal-title":"American Journal of Neuroradiology"},{"key":"10.1016\/j.msard.2013.08.006_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.0b013e318246d6d8","article-title":"Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance","volume":"78","author":"Blair","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib15","first-page":"279","article-title":"Progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis patients in Spain: more than expected?","volume":"18","author":"Castillo-Trivino","year":"2012","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.msard.2013.08.006_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib1","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/eji.200535195","article-title":"Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?","volume":"35","author":"Engelhardt","year":"2005","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.msard.2013.08.006_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(09)70021-3","article-title":"Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study","volume":"8","author":"Havrdova","year":"2009","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s00415-011-6116-8","article-title":"Progressive multifocal leukoencephalopathy and natalizumab","volume":"258","author":"Hellwig","year":"2011","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S0317167100012105","article-title":"Monoclonal antibodies and progressive multifocal leukoencephalopathy","volume":"38","author":"Keene","year":"2011","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1016\/j.msard.2013.08.006_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.08.006_bib24","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0b013e31823b9b27","article-title":"Management and outcome of CSF-JC virus PCR negative PML in a natalizumab-treated patient with MS","volume":"77","author":"Kuhle","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1212\/01.wnl.0000194227.16696.11","article-title":"Seizures and their outcome in progressive multifocal leukoencephalopathy","volume":"66","author":"Lima","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2012-302478","article-title":"Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies","volume":"83","author":"Mentzer","year":"2012","journal-title":"Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"10.1016\/j.msard.2013.08.006_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/01.wnl.0000284601.54436.e4","article-title":"Cortical demyelination in PML and MS: similarities and differences","volume":"70","author":"Moll","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib12","first-page":"S109","article-title":"Natalizumab-related PML in multiple sclerosis: a case report","volume":"259","author":"Papadopoulos","year":"2012","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJMoa044397","article-title":"AFFIRM investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.08.006_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis","volume":"354","author":"Rudick","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.08.006_bib23","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archneurol.2010.157","article-title":"Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis","volume":"67","author":"Schr\u00f6der","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1352458511435105","article-title":"Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab","volume":"18","author":"S\u00f8rensen","year":"2012","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2013.08.006_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib11","doi-asserted-by":"crossref","first-page":"P07.053","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P07.053","article-title":"Natalizumab-associated progressive multifocal leucoencephalopathy: lessons from four different cases","volume":"78","author":"Travasarou","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.08.006_bib22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1212\/WNL.0b013e31821a446b","article-title":"Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Vermersch","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.08.006_bib13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy","volume":"354","author":"Yousry","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.08.006_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"72","author":"Yousry","year":"2012","journal-title":"Annals of Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034813000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034813000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:35:23Z","timestamp":1761899723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034813000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2211034813000928"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2013.08.006","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natalizumab-related progressive multifocal leukoencephalopathy in Greece","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}